Author

Руслан Маликович Палтуев

Observed names: P M Paltuev, R M Paltuev, R. M. PALTUEV, R. M. Paltuev, R. Paltuev, R. M. Paltuev, R.M Paltuev, R.M. Paltuev, R.M. Paltuev () Paltuev, R.M. Paltuev Paltuev, R. M. Paltuev, R. M. Paltuev, Ruslan M. Paltuev, Ruslan Paltuev, Палтуев Р. М., Палтуев Р.М., Палтуев Руслан Маликович, Р. М. Палтуев

Institution: Institute of Oncology NN Petrov

Observed institutions: Russian Railways, Institute of Oncology NN Petrov, Ministry of Health of the Russian Federation, Swedish Society of Oncology

ORCID: 0000-0002-0871-9453

Observed ORCID: 0000-0002-0871-9453

OpenAlex ID: A5021050189

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer

2007 · Vladimir F. Semiglazov, Vladimir F. Semiglazov, et al. · Cancer · 333

Exemestane (E) vs tamoxifen (T) as neoadjuvant endocrine therapy for postmenopausal women with ER+ breast cancer (T2N1–2, T3N0–1, T4N0M0)

2005 · V. Semiglazov, A. Kletsel, et al. · Journal of Clinical Oncology · 84

The relative efficacy of neoadjuvant endocrine therapy vs chemotherapy in postmenopausal women with ER- positive breast cancer

2004 · V. F. Semiglazov, V. Semiglazov, et al. · Journal of Clinical Oncology · 53

2021 · Liudmila G. Zhukova, Iuliia I. Andreeva, et al. · Journal of Modern Oncology · 12

Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer

2021 · Hesham Elghazaly, Hope S. Rugo, et al. · Cancers · 12

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)

2015 · V. F. Semiglazov, R. M. Paltuev, et al. · Tumors of female reproductive system · 8

Sentinel Lymph Node Biopsy in Early Breast Cancer: the Experience of the N.n. Petrov Research Institute of Oncology

2017 · Petr Krivorotko, Konstantin Zernov, et al. · Voprosy Onkologii · 6

Results of research work Russian society of oncomammologists “The use of artificial intelligence for early detection of breast cancer”

2023 · V. I. Pavlova, Yu. A. Belaya, et al. · Tumors of female reproductive system · 5

Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study

2020 · T.Yu. Semiglazova Semiglazova, V.V. Semiglazov Semiglazov, et al. · Фарматека · 5

Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM)

2016 · A. A. Bozhok, E. E. Topuzov, et al. · Tumors of female reproductive system · 5

Preoperative hormonal therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients

2004 · V.F Semiglazov, V.V Semiglazov, et al. · European Journal of Cancer Supplements · 5

Tailoring neoadjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendations

2024 · Hesham Elghazaly, Hamdy A. Azim, et al. · Cancer · 4

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases

2021 · T. Yu. Semiglazova, S. M. Sharashenidze, et al. · Tumors of female reproductive system · 4

Biological rationale for a patient-specific approach in the treatment of breast cancer. Clinical value of novel biomarkers of breast cancer

2019 · R. M. Paltuev · Tumors of female reproductive system · 4

Neoadjuvant Endocrine Therapy for Patients With Estrogen-receptor-positive Breast Cancer

2018 · V. F. Semiglazov, V. V. Semiglazov, et al. · Siberian Journal of Oncology · 4

Melatonin and Metformin in Neoadjuvant Hormonotherapy in Locally Advanced Breast Cancer

2018 · Tatyana Semiglazova, Yevgeniya Tsyrlina, et al. · Voprosy Onkologii · 4

Breast reconstruction and radiotherapy

2017 · K. Y. ZERNOV, G. A. DASHYAN, et al. · Malignant tumours · 4

[Phase II clinical trial of neoadjuvant hormone therapy in comparison with chemotherapy of patients with breast cancer].

2007 · V F Semiglazov, V V Semiglazov, et al. · PubMed · 4

[Inflammatory breast carcinoma and prognosticators of efficacy of primary chemotherapy].

2007 · V F Semiglazov, K Iu Zernov, et al. · PubMed · 4

Predictive multigenic scale. Analysis of own results in metastatic breast cancer

2023 · R. M. Paltuev, S. N. Aleksakhina, et al. · Tumors of female reproductive system · 3

Automated Analysis of Cell Density in Breast Cancer as an Additional Method of Increasing Objectivity and Accuracy of Breast Cancer Prognosis

2017 · R. M. Paltuev, A. G. Kudabergenova, et al. · Tumors of female reproductive system · 3

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases

2016 · G. A. Dashyan, V. F. Semiglazov, et al. · Tumors of female reproductive system · 3

[Adjuvant chemotherapy for breast cancer: search for new ways of planning].

2014 · V F Semiglazov, V V Semiglazov, et al. · PubMed · 3

9 Breast-conserving surgery after preoperative endocrine therapy versus chemotherapy in postmenopausal patients with estrogen-receptor-positive breast cancer

2010 · V.F. Semiglazov, V.V. Semiglazov, et al. · European Journal of Cancer Supplements · 3

Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response

2022 · P. V. Krivorotko, V. V. Mortada, et al. · Tumors of female reproductive system · 2

Works count: 98

Citation count: 600

H-index: 6

I10-index: 5